Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.54 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | BCL2 | P10415 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.48 |
| ▸ | CTRC | Q99895 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28195073 | 1.00 | HTR2A (0.56) | HTR2ATAAR1CALM1IDO1BCL2 | |
| Fluoride SCHEMBL27939369 | 0.98 | HTR2A (0.54) | HTR2ATAAR1CALM1IDO1BCL2 | |
| SCHEMBL4853233 | 0.98 | HTR2A (0.54) | HTR2ATAAR1CALM1IDO1BCL2 | |
| Boric Acid SCHEMBL28279493 | 0.91 | HTR2A (0.48) | HTR2ATAAR1CALM1IDO1BCL2 | |
| SCHEMBL28517240 | 0.91 | HTR2A (0.48) | HTR2ATAAR1CALM1IDO1BCL2 | |
| SCHEMBL25625114 | 0.87 | TAAR1 (0.50) | HTR2ATAAR1IDO1 | |
| SCHEMBL31152647 | 0.84 | CALM1 (0.46) | HTR2ATAAR1CALM1IDO1BCL2 | |
| SCHEMBL28025161 | 0.84 | CALM1 (0.46) | HTR2ATAAR1CALM1IDO1BCL2 | |
| SCHEMBL29930048 | 0.84 | TAAR1 (0.64) | TAAR1IDO1 | |
| SCHEMBL8703610 | 0.84 | TAAR1 (0.64) | TAAR1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103435801-A | Silver chloride/porous aromatic frame composite material and preparation method thereof | SUZHOU NAAI PURIFYING SCIENCE & TECHNOLOGY CO LTD | 2013-12-11 | — | — | CN | claimed |
| US-12635404-B2 | Organometallic compound and light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-20240182463-A1 | SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG | SHIONOGI & CO., LTD. (JP) | 2024-06-06 | — | — | US | disclosed |
| US-20230158039-A1 | BROMODOMAIN INHIBITORS | ABBVIE INC (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230111588-A1 | ORGANOMETALLIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
| CN-115707324-A | Organometallic compound, light-emitting device, and electronic device | 三星显示有限公司 | 2023-02-17 | — | — | CN | disclosed |
| US-20210236508-A1 | BROMODOMAIN INHIBITORS | ABBVIE INC (US) | 2021-08-05 | — | — | US | disclosed |
| EP-2280983-B9 | C-ARYL GLYCOSIDE COMPOUNDS FOR THE TREATMENT OF DIABETES AND OBESITY | TFCHEM (FR) | 2021-06-09 | — | — | EP | disclosed |
| CN-107635970-B | Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators | 詹森药业有限公司 | 2021-03-12 | — | — | CN | disclosed |
| US-20200339565-A1 | PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE | SHIONOGI & CO., LTD. (JP) | 2020-10-29 | — | — | US | disclosed |
| EP-0063793-A2 | (Arylmethyl)aryl-amino-cyclohexanols, -cyclohexanes, -cyclohexenes and intermediates thereof, a process for preparing the same and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1982-11-03 | — | — | EP | disclosed |
| US-4313959-A | (Arylmethyl)phenyl-aminocyclohexanols, cyclohexenes and intermediates thereof | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1982-02-02 | — | — | US | disclosed |
| US-4311703-A | PYRROLIDINE AND PIPERIDINE DERIVATIVES | AMERICAN HOECHST CORPORATION (US) | 1982-01-19 | — | — | US | disclosed |
| US-4301292-A | 1-[2-(4,5-Dihydro-4,4-dialkyl-2-oxazolyl)phenyl]-4-(dialkylamino)cyclohexanol | HOECHST-ROUSSEL PHARMACEUTICALS, INCORPORATED (US) | 1981-11-17 | — | — | US | disclosed |
| US-4292245-A | 3'-Phenylspiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-one | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1981-09-29 | — | — | US | disclosed |
| US-4292243-A | 3\"-Phenyldispiro[1,3-dioxolane-2,4'-cyclohexane-1',1\"-(3\"H)-isobenzofuran] | HOECHST ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1981-09-29 | — | — | US | disclosed |
| US-4290958-A | Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1981-09-22 | — | — | US | disclosed |
| US-4288623-A | 1-Aryl-4-amino-cyclohexan-1-ols | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1981-09-08 | — | — | US | disclosed |
| US-4263317-A | Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1981-04-21 | — | — | US | disclosed |
| US-4241071-A | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes | AMERICAN HOECHST CORPORATION (US) | 1980-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240182463-A1 | SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG | PREP, UNG, DPP4 | HTR2A 3244/4885TAAR1 4505/4885CALM1 3822/4885 |
| US-20230111588-A1 | ORGANOMETALLIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME | SOD1, AP1M1, GPS1 | HTR2A 4859/4885TAAR1 1963/4885CALM1 4316/4885 |
| US-20230158039-A1 | BROMODOMAIN INHIBITORS | BRD4, BRD1, BRD3 | HTR2A 2225/4885TAAR1 577/4885CALM1 749/4885 |
| US-20200339565-A1 | PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE | PREP, UNG, DPP4 | HTR2A 3231/4885TAAR1 4460/4885CALM1 3823/4885 |
| US-12635404-B2 | Organometallic compound and light-emitting device including the same | SOD1, GPS1, SLC39A11 | HTR2A 4867/4885TAAR1 2787/4885CALM1 4374/4885 |
| US-20210236508-A1 | BROMODOMAIN INHIBITORS | BRD4, BRD1, BRD3 | HTR2A 2225/4885TAAR1 577/4885CALM1 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.